FIELD: chemistry.
SUBSTANCE: present invention relates to a method for synthesis of 2-methyl-1-(2-methylpropyl)-1H-imidazo[4.5-c][1.5]naphthyridine-4-amine. The method involves the following: 2-methyl-1-(2-methypropyl)-5-oxido-1H-imidazo[4.5-c][1.5]naphthyridine is obtained in a carrier which contains lower alcohol; the 2-methyl-1-(2-methypropyl)-5-oxido-1H-imidazo[4.5-c][1.5]naphthyridine in the carrier is combined with a reagent which contains ammonia or ammonium and arylsulfonyl halide to form a mixture; and components of the mixture can react in a period of time sufficient for formation of 2-methyl-1-(2-methylpropyl)-1H-imidazo[4.5-c][1.5]naphthyridine-4-amine.
EFFECT: obtaining a new compound.
67 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SYNTHESIS OF DERIVATIVES OF 2-CHLORO-NITROQUINOLINEAMINES, METHOD OF SYNTHESIS OF 2-CHLORO-3,4-DIAMINOQUINOLINES, METHOD OF SYNTHESIS OF DERIVATIVES OF 4-CHLORO-1H-IMIDAZO-[4,5-C]-QUINOLINES, METHOD OF SYNTHESIS OF DERIVATIVE OF 1H-IMIDAZO-[4,5-C]-QUINOLINES, 2-CHLORO-3-NITROAMINOQUINOLINE, 2-CHLORO-3,4-DIAMINOQUINOLINE | 1990 |
|
RU2083563C1 |
TRANSGLUTAMINASE 2 (TG2) INHIBITORS | 2019 |
|
RU2781370C2 |
PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS MODULATORS OF LEUCINE-REPEATING KINASE 2 | 2013 |
|
RU2637947C2 |
PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS LEUCINE-REPEATING KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON DISEASE | 2013 |
|
RU2637948C2 |
N-{2-[4-AMINO-2-(ETHOXYMETHYL)-1H-IMIDAZO-[4,5-c]-QUINOLIN-1-YL]-1,1-DIMETHYLETHYL}-METHANESULFONAMIDE AND PHARMACEUTICAL COMPOSITON BASED ON SAID COMPOUND | 2004 |
|
RU2374246C2 |
N4-PHENYLQUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS RECEPTOR TYROSINE KINASE TYPE ERBB INIHIBITORS FOR TREATING HYPERPROLIFERATIVE DISEASES | 2006 |
|
RU2428421C2 |
IMIDAZOQUINOLINE COMPOUNDS | 2005 |
|
RU2415857C2 |
NEW DERIVATIVES OF IMIDAZO [4,5-C] QUINOLINES AND IMIDAZO [4,5-C] [1,5] NAPHTHYRIDINES AS LRRK2 INHIBITORS | 2016 |
|
RU2722149C1 |
INHIBITORS OF TYPE ErbB INHIBITORS | 2006 |
|
RU2592703C9 |
IMIDAZO[4,5-C]PYRIDINE DERIVATIVES AS TOLL-LIKE RECEPTOR AGONISTS | 2020 |
|
RU2785124C1 |
Authors
Dates
2010-05-10—Published
2005-12-28—Filed